Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Morgan Stanley Resumes Abercrombie & Fitch (ANF) at Equalweight
• HSBC sees more upside in Intel stock on server CPU opportunity